Discover the latest insights & resources from ROIS below

CDMO Partnerships: Why Speed and Flexibility Matter Now More Than Ever

What used to be acceptable in 18 months, clients now want in 9 – with particular urgency for GLP-1s and biologics.

Scaling for the GLP-1 Revolution - Meeting Global Injectable Demand

It’s not just about being fast. It’s about being reliable and ready.